<DOC>
	<DOCNO>NCT00617877</DOCNO>
	<brief_summary>The purpose study evaluate antihypertensive response treatment losartan reference genetic polymorphism .</brief_summary>
	<brief_title>Antihypertensive Response Losartan Genetic Polymorphisms</brief_title>
	<detailed_description />
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Both gender less 60 year old , mildmoderate hypertension ( SBP great DBP equal great 90 mmhg , BP &lt; 180/110 ) Never treat hypertension take antihypertensive agent sporadically ( 15 day total therapy ) 30 day prior first visit Patient therapeutic wash 6 month Patient asymptomatic , absence significant concomitant disease , except nonfamilial hypercholesterolemia , absence systemic disease Women menopause treat hormone replacement therapy woman reproductive age make use estroprogestagen agent use another safe contraceptive method BMI &lt; 30 men &lt; 28 woman Secondary malignant hypertension , Na &lt; 130 mmol/l , K &gt; 5,5 mmol/l , &lt; 3,0 mmol/l Cardiac disease ischemic , HF , arrhythmia , cardiac surgery Pregnant , breast feed History nephropathy , metabolic disease , liver disease Alcohol drug abuse History angioedema Has know hypersensibility study drug ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>